Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

Chenodeoxycholic acid - 98%, high purity , Bile acid receptor FXR agonist, CAS No.474-25-9, Bile acid receptor FXR agonist

Item Number
C104902
Grouped product items
SKUSizeAvailabilityPrice Qty
C104902-5g
5g
In stock
$141.90
C104902-25g
25g
In stock
$317.90
C104902-100g
100g
In stock
$1,142.90
C104902-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$5,140.90
Add to Wish List Compare
Bulk Order  SDS  DATASHEET

Major bile acids component

View related series
Steroids

Basic Description

Synonymschenodeoxycholic acid | Chenodiol | 474-25-9 | Chenix | Chenic acid | Cdca | Chenodesoxycholic acid | Chenodeoxycholate | Gallodesoxycholic acid | Chendol | Anthropodeoxycholic acid | Anthropodesoxycholic acid | Anthropododesoxycholic acid | Chenofalk | Chenodesoxycholsaeure | Chenoco
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsChenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nuclear receptors involved in cholesterol metabolism. Bile acids are essential for solubilization and transport of dietary lipids, are the major products of cholesterol catabo
Storage TempStore at 2-8°C,Protected from light
Shipped InWet ice
GradeMoligand™
Action TypeAGONIST
Mechanism of actionBile acid receptor FXR agonist
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Chenodeoxycholic Acid, Free Acid and its 7β-isomer ursodeoxycholic acid are potent (nanomolar affinity) selective inhibitors of DD2 (AKR1C2). These compounds were non-competitive inhibitors of AKR1D1 yielding Ki values of 3.2 μM for chenodeoxycholic acid. This chemical is a hydrophobic primary bile acid, which increases intracellular Ca2+ in rat hepatocyte couplets. Studies indicate that Chenodeoxycholic Acid induces apoptosis through a PKC dependent pathway. It is known that Chenodeoxycholic Acid is essential in the metabolism of cholesterol via activation of nuclear receptors. This bile acid can also bind to BABP with a stoichiometery of 1:2. Alternate studies indicate that chenodeoxycholic acid can inhibit the expression of IL-6 and cell viability in QBC939 cells.
An apoptosis inducer via PKC-dependent signalling pathway.

Product Properties

ALogP4.9

Associated Targets(Human)

FPR1 Tchem fMet-Leu-Phe receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NR1H4 Tclin Bile acid receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GPBAR1 Tchem G-protein coupled bile acid receptor 1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALB Tchem Serum albumin (2651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LTB4R2 Tchem Leukotriene B4 receptor 2 (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PLA2G1B Phospholipase A2 group 1B (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clostridioides difficile (2968 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
3T3-L1 (3664 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc10a1 Bile acid transporter (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr1h4 Bile acid receptor (142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Danio rerio (3092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mdr1a Multidrug resistance protein 1a (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slco1a1 Solute carrier organic anion transporter family member 1A1 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc10a2 Ileal sodium/bile acid cotransporter (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc10a1 Sodium/bile acid cotransporter (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rxra Bile acid receptor/Retinoic acid receptor RXR-alpha (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
INCHI InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1
InChi Key RUDATBOHQWOJDD-BSWAIDMHSA-N
Canonical SMILES CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
Isomeric SMILES C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
PubChem CID 10133
Molecular Weight 392.58

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

1 results found

Lot NumberCertificate TypeDateItem
B2327569Certificate of AnalysisJan 03, 2023 C104902

Chemical and Physical Properties

SolubilitySoluble in ethanol (~20 mg/ml), methanol, acetone, glacial acetic acid, DMF, DMSO, and 1:1 DMF:PBS(pH 7.2) (~0.5 mg/ml). Insoluble in water.
SensitivityLight sensitive.

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H302:Harmful if swallowed

H312:Harmful in contact with skin

H332:Harmful if inhaled

H361:Suspected of damaging fertility or the unborn child

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P317:Get emergency medical help.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

Merck Index 2054

Related Documents

 SDS

 Specification Sheet

Citations of This Product

1. Jingyi Hu,Hai Huang,Yuan Che,Chujie Ding,Lu Zhang,Yun Wang,Haiping Hao,Hong Shen,Lijuan Cao.  (2020-09-18)  Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function..  Journal of ethnopharmacology,  266  (113394-113394).  [PMID:32941971]
2. Mu-Qiang Wang, Zhi-Neng You, Bing-Yi Yang, Zi-Wei Xia, Qi Chen, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2023)  Machine-Learning-Guided Engineering of an NADH-Dependent 7β-Hydroxysteroid Dehydrogenase for Economic Synthesis of Ursodeoxycholic Acid.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,  71  (49): (19672–19681).  [PMID:38016669]
3. Jiang-Tao Xue, Zhi-Neng You, Bing-Yi Yang, Zheng-Yu Huang, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2024)  Efficient synthesis of 7-oxo-lithocholic acid using a newly identified 7α-hydroxysteroid dehydrogenase.  Molecular Catalysis,  553  (113739).  [PMID:]
4. Qing-Lin Li, Hua Zheng, Zhi Luo, Li-Xiang Wu, Peng-Cheng Xu, Jia-Cheng Guo, Yu-Feng Song, Xiao-Ying Tan.  (2024)  Characterization and expression analysis of seven lipid metabolism-related genes in yellow catfish Pelteobagrus fulvidraco fed high fat and bile acid diet.  GENE,  894  (13): (147972).  [PMID:37944648]
5. Hua Zheng, Yi-Chuang Xu, Tao Zhao, Zhi Luo, Dian-Guang Zhang, Chang-Chun Song, An-Gen Yu, Xiaoying Tan.  (2023)  Dietary chenodeoxycholic acid attenuates high-fat diet-induced growth retardation, lipid accumulation and bile acid metabolism disorder in the liver of yellow catfish Pelteobagrus fulvidraco.  BRITISH JOURNAL OF NUTRITION,    (6): (1-14).  [PMID:37905695]
6. Zhiyuan Meng, Sen Yan, Wei Sun, Jin Yan, Miaomiao Teng, Ming Jia, Sinuo Tian, Zhiqiang Zhou, Wentao Zhu.  (2023)  Chlorothalonil induces obesity in mice by regulating host gut microbiota and bile acids metabolism via FXR pathways.  JOURNAL OF HAZARDOUS MATERIALS,  452  (131310).  [PMID:37003002]
7. Shuai Liu, Keming Zheng, Yilin Jiang, Susu Gai, Bohan Li, Dehai Li, Shuang Yang, Zhihua Lv.  (2023)  Biotransformation of Penindolone, an Influenza A Virus Inhibitor.  MOLECULES,  28  (3): (1479).  [PMID:36771146]
8. Bing-Yi Yang, Zhi-Neng You, Jiang-Tao Xue, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2023)  Clean enzymatic production of ursodeoxycholic acid enabled by a newly identified NADH-dependent 7β-hydroxysteroid dehydrogenase.  Molecular Catalysis,  537  (112946).  [PMID:]
9. Jia Xu, Chaozhong Zheng, Shuyan Chi, Shuang Zhang, Junming Cao, Beiping Tan, Shiwei Xie.  (2023)  Clostridium autoethanogenum protein substitution and bile acids addition altered intestinal health and transcriptome profiles of hepatopancreas in Litopenaeus vannamei.  Aquaculture Reports,  28  (101432).  [PMID:]
10. Jiating Zheng, Xiaoru Peng, Taifeng Zhu, Shuyao Huang, Chao Chen, Guosheng Chen, Shuqin Liu, Gangfeng Ouyang.  (2022)  Detection of bile acids in small volume human bile samples via an amino metal-organic framework composite based solid-phase microextraction probe.  JOURNAL OF CHROMATOGRAPHY A,  1685  (463634).  [PMID:36345074]
11. Wei Xu, Yingying Kong, Tuo Zhang, Zhihua Gong, Wenjun Xiao.  (2022)  L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.  JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE,  103  (3): (1283-1293).  [PMID:36087337]
12. Ma Wen, Yang Bingxin, Li Jun, Liu Mingxia, Li Xianjiang, Liu Huwei.  (2022)  Maltose-functional metal–organic framework assisted laser desorption/ionization mass spectrometry for small biomolecule determination.  MICROCHIMICA ACTA,  189  (7): (1-8).  [PMID:35689150]
13. Xiaoxu Cheng, Zifeng Pi, Zhong Zheng, Shu Liu, Fengrui Song, Zhiqiang Liu.  (2022)  Combined 16S rRNA gene sequencing and metabolomics to investigate the protective effects of Wu-tou decoction on rheumatoid arthritis in rats.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,  1199  (123249).  [PMID:35447521]
14. Hai-Peng Li, Zhi-Neng You, Yuan-Yang Liu, Gao-Wei Zheng, Heng Gong, Yiming Mo, Ning Zhu, Yun-Peng Bai, Jian-He Xu.  (2022)  Continuous-Flow Microreactor-Enhanced Clean NAD+ Regeneration for Biosynthesis of 7-Oxo-lithocholic Acid.  ACS Sustainable Chemistry & Engineering,  10  (1): (456–463).  [PMID:]
15. Ding Shen, Wei Hu, Suqing Zhao, Chuanbin Mao.  (2021)  Rapid Naked-Eye Detection of a Liver Disease Biomarker by Discovering Its Monoclonal Antibody to Functionalize Engineered Red-Colored Bacteria Probes.  ACS Omega,  6  (47): (32005–32010).  [PMID:34870023]
16. Shuai Xue,Jianli Yin,Jiawei Shao,Yuanhuan Yu,Linfeng Yang,Yidan Wang,Mingqi Xie,Martin Fussenegger,Haifeng Ye.  (2017-02-06)  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes..  Molecular therapy : the journal of the American Society of Gene Therapy,  25  ((2)): (443-455).  [PMID:28153094]
17. Chunli Qi,Jiangnan Fu,Huinan Zhao,Huijie Xing,Dong Dong,Baojian Wu.  (2018-02-14)  Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin..  Xenobiotica; the fate of foreign compounds in biological systems,  49  ((3)): (276-283).  [PMID:29436891]

References

1. Pellicciari R, Sato H, Gioiello A, Costantino G, Macchiarulo A, Sadeghpour BM, Giorgi G, Schoonjans K, Auwerx J.  (2007)  Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5..  J Med Chem,  50  (18): (4265-8).  [PMID:17685603]
2. Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, Saladin R, Schoonjans K, Pellicciari R, Auwerx J.  (2008)  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies..  J Med Chem,  51  (6): (1831-41).  [PMID:18307294]
3. K Nikkilä,K Höckerstedt,T A Miettinen.  (1991-04-01)  High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation..  Hepatology (Baltimore, Md.),  13  ((4)): (663-669).  [PMID:2010161]
4. M Donaghy,R H King,R O McKeran,M S Schwartz,P K Thomas.  (1990-06-01)  Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid..  Journal of neurology,  237  ((3)): (216-219).  [PMID:2196342]
5. A Stiehl,R Raedsch,G Rudolph.  (1990-02-01)  Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids..  Gastroenterology,  98  ((2)): (424-428).  [PMID:2295398]
6. A K Batta,R Arora,G Salen,G S Tint,D Eskreis,S Katz.  (1989-12-01)  Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment..  Journal of lipid research,  30  ((12)): (1953-1962).  [PMID:2621422]
7. R H Dowling.  (1974-07-01)  The goose that laid the golden bile: gallstone dissolution in man with chenodeoxycholic acid..  Irish journal of medical science,    ((0)): (suppl:115-suppl:127).  [PMID:4212419]
8. S Hillaire,F Ballet,D Franco,K D Setchell,R Poupon.  (1995-07-01)  Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture..  Hepatology (Baltimore, Md.),  22  ((1)): (82-87).  [PMID:7601437]
9. M Stark,H Jörnvall,J Johansson.  (1999-10-29)  Isolation and characterization of hydrophobic polypeptides in human bile..  European journal of biochemistry,  266  ((1)): (209-214).  [PMID:10542066]
10. K V Kowdley.  (2000-04-27)  Ursodeoxycholic acid therapy in hepatobiliary disease..  The American journal of medicine,  108  ((6)): (481-486).  [PMID:10781781]
11. M Nobilis,M Pour,J Kunes,J Kopecký,J Kvĕtina,Z Svoboda,K Sládková,J Vortel.  (2001-03-15)  High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization..  Journal of pharmaceutical and biomedical analysis,  24  ((5-6)): (937-946).  [PMID:11248487]
12. M V St-Pierre,G A Kullak-Ublick,B Hagenbuch,P J Meier.  (2001-04-24)  Transport of bile acids in hepatic and non-hepatic tissues..  The Journal of experimental biology,  204  ((Pt 10)): (1673-1686).  [PMID:11316487]
13. Roger A Davis,Jon H Miyake,To Yuen Hui,Nathanael J Spann.  (2002-03-22)  Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP..  Journal of lipid research,  43  ((4)): (533-543).  [PMID:11907135]
14. Markus Gatzen,Jürgen Pausch.  (2002-04-18)  [Treatment of cholestatic liver diseases]..  Medizinische Klinik (Munich, Germany : 1983),  97  ((3)): (152-159).  [PMID:11957790]
15. John Y L Chiang.  (2003-02-11)  Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors..  American journal of physiology. Gastrointestinal and liver physiology,  284  ((3)): (G349-G356).  [PMID:12576301]
16. Thierry Claudel,Bart Staels,Folkert Kuipers.  (2005-07-23)  The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism..  Arteriosclerosis, thrombosis, and vascular biology,  25  ((10)): (2020-2030).  [PMID:16037564]
17. Masahiko Kainuma,Jun-ichi Kasuga,Shinnosuke Hosoda,Ken-ichi Wakabayashi,Aya Tanatani,Kazuo Nagasawa,Hiroyuki Miyachi,Makoto Makishima,Yuichi Hashimoto.  (2006-04-18)  Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligands..  Bioorganic & medicinal chemistry letters,  16  ((12)): (3213-3218).  [PMID:16617018]
18. Hsiang-Ru Lin,Donald J Abraham.  (2006-06-21)  Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents..  Bioorganic & medicinal chemistry letters,  16  ((16)): (4178-4183).  [PMID:16784849]
19. Roberto Pellicciari,Antimo Gioiello,Gabriele Costantino,Bahman M Sadeghpour,Giovanni Rizzo,Udo Meyer,Derek J Parks,Antonio Entrena-Guadix,Stefano Fiorucci.  (2006-07-11)  Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives..  Journal of medicinal chemistry,  49  ((14)): (4208-4215).  [PMID:16821780]
20. Bryson W Katona,Carolyn L Cummins,Andrew D Ferguson,Tingting Li,Daniel R Schmidt,David J Mangelsdorf,Douglas F Covey.  (2007-10-30)  Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids..  Journal of medicinal chemistry,  50  ((24)): (6048-6058).  [PMID:17963371]
21. Alfonso Pérez-Garrido,Aliuska Morales Helguera,Adela Abellán Guillén,M Natália D S Cordeiro,Amalio Garrido Escudero.  (2008-12-06)  Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins..  Bioorganic & medicinal chemistry,  17  ((2)): (896-904).  [PMID:19056282]
22. Denis Fourches,Julie C Barnes,Nicola C Day,Paul Bradley,Jane Z Reed,Alexander Tropsha.  (2009-12-18)  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species..  Chemical research in toxicology,  23  ((1)): (171-183).  [PMID:20014752]
23. Dominique Brossard,Laïla El Kihel,Monique Clément,Walae Sebbahi,Mohamed Khalid,Christos Roussakis,Sylvain Rault.  (2010-04-13)  Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines..  European journal of medicinal chemistry,  45  ((7)): (2912-2918).  [PMID:20381215]
24. Nigel Greene,Lilia Fisk,Russell T Naven,Reine R Note,Mukesh L Patel,Dennis J Pelletier.  (2010-06-18)  Developing structure-activity relationships for the prediction of hepatotoxicity..  Chemical research in toxicology,  23  ((7)): (1215-1222).  [PMID:20553011]
25. Sean Ekins,Antony J Williams,Jinghai J Xu.  (2010-09-17)  A predictive ligand-based Bayesian model for human drug-induced liver injury..  Drug metabolism and disposition: the biological fate of chemicals,  38  ((12)): (2302-2308).  [PMID:20843939]
26. Luciano Adorini,Mark Pruzanski,David Shapiro.  (2012-06-02)  Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis..  Drug discovery today,  17  ((17-18)): (988-997).  [PMID:22652341]
27. Dominik Wiemuth,Hacer Sahin,Björn H Falkenburger,Cathérine M T Lefèvre,Hermann E Wasmuth,Stefan Gründer.  (2012-06-28)  BASIC--a bile acid-sensitive ion channel highly expressed in bile ducts..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology,  26  ((10)): (4122-4130).  [PMID:22735174]
28. Ivan Casaburi,Paola Avena,Marilena Lanzino,Diego Sisci,Francesca Giordano,Pamela Maris,Stefania Catalano,Catia Morelli,Sebastiano Andò.  (2012-07-04)  Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation..  Cell cycle (Georgetown, Tex.),  11  ((14)): (2699-2710).  [PMID:22751440]
29. Zhizhen Xu,Gang Huang,Wei Gong,Yuanyin Zhao,Peng Zhou,Yijun Zeng,Fengtian He.  (2012-07-24)  Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells..  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,  32  ((11)): (517-523).  [PMID:22817871]
30. Dong Liang,Qing Zhou,Jiuliang Zhang,Wei Gong,Chuanrui Xu,Bin Li,Yi Wang,Jiangtao Li.  (2012-09-15)  A novel chenodeoxycholic acid-verticinone ester induces apoptosis and cell cycle arrest in HepG2 cells..  Steroids,  77  ((13)): (1381-1390).  [PMID:22974827]
31. R Zhang,H-H Ran,Y-X Zhang,P Liu,C-Y Lu,Q Xu,Y Huang.  (2012-10-17)  Farnesoid X receptor regulates vascular reactivity through nitric oxide mechanism..  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,  63  ((4)): (367-372).  [PMID:23070085]
32. V V Kollerov,D Monti,N O Deshcherevskaya,T G Lobastova,E E Ferrandi,A Larovere,S A Gulevskaya,S Riva,M V Donova.  (2013-01-22)  Hydroxylation of lithocholic acid by selected actinobacteria and filamentous fungi..  Steroids,  78  ((3)): (370-378).  [PMID:23333587]
33. Lin Yang,J Paul Fawcett,Hu Zhang,Ian G Tucker.  (2013-03-16)  Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats..  The Journal of pharmacy and pharmacology,  65  ((4)): (561-566).  [PMID:23488785]
34. F A R Lívero,Aline Maria Stolf,Arturo Alejandro Dreifuss,Amanda Leite Bastos-Pereira,Raphaella Chicorski,Liana Gomes de Oliveira,Carlos Eduardo Alves de Souza,Isabella Aviles Fabossi,I S Rabitto,Luiza Helena Gremski,Raílson Henneberg,José Ederaldo Queiroz Telles,Ronald P J Oude Elferink,Alexandra Acco.  (2014-04-10)  The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice..  Chemico-biological interactions,  217  (19-27).  [PMID:24713361]
35. Yunpeng Qi,Changtao Jiang,Jie Cheng,Kristopher W Krausz,Tiangang Li,Jessica M Ferrell,Frank J Gonzalez,John Y L Chiang.  (2014-05-07)  Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice..  Biochimica et biophysica acta,  1851  ((1)): (19-29).  [PMID:24796972]
36. Liping Yang,David Broderick,Yuan Jiang,Victor Hsu,Claudia S Maier.  (2014-06-24)  Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone..  Biochimica et biophysica acta,  1844  ((9)): (1684-1693).  [PMID:24953769]
37. Diana Vivian,James E Polli.  (2014-09-16)  Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver..  International journal of pharmaceutics,  475  ((1-2)): (597-604).  [PMID:25219859]
38. Nianbai Fang,Shanggong Yu,Martin Jj Ronis,Thomas M Badger.  (2014-10-12)  Matrix effects break the LC behavior rule for analytes in LC-MS/MS analysis of biological samples..  Experimental biology and medicine (Maywood, N.J.),  240  ((4)): (488-497).  [PMID:25304311]
39. Yan-Dong Wang,Wei-Dong Chen,Cunbao Li,Cong Guo,Yanyan Li,Hui Qi,Hailing Shen,Jing Kong,Xuecheng Long,Frank Yuan,Xichun Wang,Wendong Huang.  (2014-12-17)  Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3..  Molecular endocrinology (Baltimore, Md.),  29  ((2)): (322-331).  [PMID:25496033]
40. Liliya Vinarova,Zahari Vinarov,Borislava Damyanova,Slavka Tcholakova,Nikolai Denkov,Simeon Stoyanov.  (2015-03-17)  Mechanisms of cholesterol and saturated fatty acid lowering by Quillaja saponaria extract, studied by in vitro digestion model..  Food & function,  6  ((4)): (1319-1330).  [PMID:25773645]
41. Xiaoyan Chu,Shian-Jiun Shih,Rachel Shaw,Hannes Hentze,Grace H Chan,Karen Owens,Shubing Wang,Xiaoxin Cai,Deborah Newton,Jose Castro-Perez,Gino Salituro,Jairam Palamanda,Aaron Fernandis,Choon Keow Ng,Andy Liaw,Mary J Savage,Raymond Evers.  (2015-03-31)  Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans..  Drug metabolism and disposition: the biological fate of chemicals,  43  ((6)): (851-863).  [PMID:25813937]
42. Charles Robb Flynn,Vance L Albaugh,Steven Cai,Joyce Cheung-Flynn,Phillip E Williams,Robert M Brucker,Seth R Bordenstein,Yan Guo,David H Wasserman,Naji N Abumrad.  (2015-07-22)  Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery..  Nature communications,  6  (7715-7715).  [PMID:26197299]
43. Jennifer Haggarty,Madalina Oppermann,Matthew J Dalby,Richard J Burchmore,Ken Cook,Stefan Weidt,Karl E V Burgess.  (2015-09-15)  Serially coupling hydrophobic interaction and reversed-phase chromatography with simultaneous gradients provides greater coverage of the metabolome..  Metabolomics : Official journal of the Metabolomic Society,  11  ((5)): (1465-1470).  [PMID:26366140]
44. Elizabeth A Rondini,Asmita Pant,Thomas A Kocarek.  (2015-10-03)  Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes..  The Journal of pharmacology and experimental therapeutics,  355  ((3)): (429-441).  [PMID:26427720]
45. Kent A Willis,Charles K Gomes,Prahlad Rao,Dejan Micic,E Richard Moran,Erin Stephenson,Michelle Puchowicz,Qusai Al Abdallah,Tahliyah S Mims,Ankush Gosain,Dengping Yin,Ajay J Talati,Eugene B Chang,Joan C Han,Joseph F Pierre.  (2020-01-07)  TGR5 signaling mitigates parenteral nutrition-associated liver disease..  American journal of physiology. Gastrointestinal and liver physiology,  318  ((2)): (G322-G335).  [PMID:31905022]
46. Jianlong Du,Qiang Chen,Yongnan Li,Xiaojun Xiang,Wei Xu,Kangsen Mai,Qinghui Ai.  (2020-07-03)  Activation of the Farnesoid X Receptor (FXR) Suppresses Linoleic Acid-Induced Inflammation in the Large Yellow Croaker (Larimichthys crocea)..  The Journal of nutrition,  150  ((9)): (2469-2477).  [PMID:32614453]
47. Jingyi Hu,Hai Huang,Yuan Che,Chujie Ding,Lu Zhang,Yun Wang,Haiping Hao,Hong Shen,Lijuan Cao.  (2020-09-18)  Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function..  Journal of ethnopharmacology,  266  (113394-113394).  [PMID:32941971]
48. R H Dowling.  (1977-01-01)  Chenodeoxycholic acid therapy of gallstones..  Clinics in gastroenterology,  6  ((1)): (141-163).  [PMID:330046]
49. .  (1976-01-01)  Chenodeoxycholic acid in the dissolution of gallstones..  Nutrition reviews,  34  ((1)): (20-21).  [PMID:814508]
50. L J Schoenfield,J M Lachin.  (1981-09-01)  Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety..  Annals of internal medicine,  95  ((3)): (257-282).  [PMID:7023307]
51. S A Azer,S A Coverdale,K Byth,G C Farrell,N H Stacey.  (1996-03-01)  Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease..  Journal of gastroenterology and hepatology,  11  ((3)): (208-215).  [PMID:8742915]
52. M O Osman,J U Kristensen,N O Jacobsen,S B Lausten,B Deleuran,M Deleuran,B Gesser,K Matsushima,C G Larsen,S L Jensen.  (1999-04-06)  A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits..  Gut,  43  ((2)): (232-239).  [PMID:10189850]
53. A F Hofmann.  (1999-12-22)  The continuing importance of bile acids in liver and intestinal disease..  Archives of internal medicine,  159  ((22)): (2647-2658).  [PMID:10597755]
54. Lucija Virović,Vladimir Supanc,Marko Duvnjak.  (2003-10-30)  [Primary sclerosing cholangitis--diagnosis and therapy]..  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,  57  ((3)): (207-219).  [PMID:14582467]
55. Kazufumi Dohmen,Toshihiko Mizuta,Makoto Nakamuta,Naoya Shimohashi,Hiromi Ishibashi,Kyosuke Yamamoto.  (2004-03-25)  Fenofibrate for patients with asymptomatic primary biliary cirrhosis..  World journal of gastroenterology,  10  ((6)): (894-898).  [PMID:15040040]
56. Ulrike Grienke,Judit Mihály-Bison,Daniela Schuster,Taras Afonyushkin,Markus Binder,Shu-hong Guan,Chun-ru Cheng,Gerhard Wolber,Hermann Stuppner,De-an Guo,Valery N Bochkov,Judith M Rollinger.  (2011-10-22)  Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum..  Bioorganic & medicinal chemistry,  19  ((22)): (6779-6791).  [PMID:22014750]
57. Huang Huang,Ying Yu,Zhenting Gao,Yong Zhang,Chenjing Li,Xing Xu,Hui Jin,Wenzhong Yan,Ruoqun Ma,Jin Zhu,Xu Shen,Hualiang Jiang,Lili Chen,Jian Li.  (2012-08-07)  Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonists..  Journal of medicinal chemistry,  55  ((16)): (7037-7053).  [PMID:22862148]
58. Jonathan H McKinnon,E Peter Bosch.  (2012-08-08)  Clinical reasoning: a case of treatable spastic paraparesis..  Neurology,  79  ((6)): (e50-e53).  [PMID:22869688]
59. Alan R Zinsmeister,Duane Burton,Michael Camilleri.  (2012-08-25)  Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations..  Digestive diseases and sciences,  58  ((2)): (509-518).  [PMID:22918691]
60. Wenlong Li,Zhiwei Cheng,Yuefei Wang,Haibin Qu.  (2012-10-24)  A study on the use of near-infrared spectroscopy for the rapid quantification of major compounds in Tanreqing injection..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  101  (1-7).  [PMID:23089462]
61. Y van der Meer,W J J Gerrits,M van den Bosch,J J Holst,M Moreto,W A Buurman,W Kulik,T A T G van Kempen.  (2013-02-13)  Chenodeoxycholic acid reduces intestinal permeability in newly weaned piglets..  Journal of animal science,  90 Suppl 4  (302-304).  [PMID:23365361]
62. Wim F P M Van den Hof,Ainhoa Ruiz-Aracama,Anke Van Summeren,Danyel G J Jennen,Stan Gaj,Maarten L J Coonen,Karen Brauers,Will K W H Wodzig,Joost H M van Delft,Jos C S Kleinjans.  (2015-01-07)  Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro..  Toxicology in vitro : an international journal published in association with BIBRA,  29  ((3)): (489-501).  [PMID:25562108]
63. Pellicciari R, Gioiello A, Macchiarulo A, Thomas C, Rosatelli E, Natalini B, Sardella R, Pruzanski M, Roda A, Pastorini E et al..  (2009)  Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity..  J Med Chem,  52  (24): (7958-61).  [PMID:20014870]
64. Mu-Qiang Wang, Zhi-Neng You, Bing-Yi Yang, Zi-Wei Xia, Qi Chen, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2023)  Machine-Learning-Guided Engineering of an NADH-Dependent 7β-Hydroxysteroid Dehydrogenase for Economic Synthesis of Ursodeoxycholic Acid.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,  71  (49): (19672–19681).  [PMID:38016669]
65. Jiang-Tao Xue, Zhi-Neng You, Bing-Yi Yang, Zheng-Yu Huang, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2024)  Efficient synthesis of 7-oxo-lithocholic acid using a newly identified 7α-hydroxysteroid dehydrogenase.  Molecular Catalysis,  553  (113739).  [PMID:]
66. Qing-Lin Li, Hua Zheng, Zhi Luo, Li-Xiang Wu, Peng-Cheng Xu, Jia-Cheng Guo, Yu-Feng Song, Xiao-Ying Tan.  (2024)  Characterization and expression analysis of seven lipid metabolism-related genes in yellow catfish Pelteobagrus fulvidraco fed high fat and bile acid diet.  GENE,  894  (13): (147972).  [PMID:37944648]
67. Hua Zheng, Yi-Chuang Xu, Tao Zhao, Zhi Luo, Dian-Guang Zhang, Chang-Chun Song, An-Gen Yu, Xiaoying Tan.  (2023)  Dietary chenodeoxycholic acid attenuates high-fat diet-induced growth retardation, lipid accumulation and bile acid metabolism disorder in the liver of yellow catfish Pelteobagrus fulvidraco.  BRITISH JOURNAL OF NUTRITION,    (6): (1-14).  [PMID:37905695]
68. Zhiyuan Meng, Sen Yan, Wei Sun, Jin Yan, Miaomiao Teng, Ming Jia, Sinuo Tian, Zhiqiang Zhou, Wentao Zhu.  (2023)  Chlorothalonil induces obesity in mice by regulating host gut microbiota and bile acids metabolism via FXR pathways.  JOURNAL OF HAZARDOUS MATERIALS,  452  (131310).  [PMID:37003002]
69. Shuai Liu, Keming Zheng, Yilin Jiang, Susu Gai, Bohan Li, Dehai Li, Shuang Yang, Zhihua Lv.  (2023)  Biotransformation of Penindolone, an Influenza A Virus Inhibitor.  MOLECULES,  28  (3): (1479).  [PMID:36771146]
70. Bing-Yi Yang, Zhi-Neng You, Jiang-Tao Xue, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2023)  Clean enzymatic production of ursodeoxycholic acid enabled by a newly identified NADH-dependent 7β-hydroxysteroid dehydrogenase.  Molecular Catalysis,  537  (112946).  [PMID:]
71. Jia Xu, Chaozhong Zheng, Shuyan Chi, Shuang Zhang, Junming Cao, Beiping Tan, Shiwei Xie.  (2023)  Clostridium autoethanogenum protein substitution and bile acids addition altered intestinal health and transcriptome profiles of hepatopancreas in Litopenaeus vannamei.  Aquaculture Reports,  28  (101432).  [PMID:]
72. Jiating Zheng, Xiaoru Peng, Taifeng Zhu, Shuyao Huang, Chao Chen, Guosheng Chen, Shuqin Liu, Gangfeng Ouyang.  (2022)  Detection of bile acids in small volume human bile samples via an amino metal-organic framework composite based solid-phase microextraction probe.  JOURNAL OF CHROMATOGRAPHY A,  1685  (463634).  [PMID:36345074]
73. Wei Xu, Yingying Kong, Tuo Zhang, Zhihua Gong, Wenjun Xiao.  (2022)  L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.  JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE,  103  (3): (1283-1293).  [PMID:36087337]
74. Ma Wen, Yang Bingxin, Li Jun, Liu Mingxia, Li Xianjiang, Liu Huwei.  (2022)  Maltose-functional metal–organic framework assisted laser desorption/ionization mass spectrometry for small biomolecule determination.  MICROCHIMICA ACTA,  189  (7): (1-8).  [PMID:35689150]
75. Xiaoxu Cheng, Zifeng Pi, Zhong Zheng, Shu Liu, Fengrui Song, Zhiqiang Liu.  (2022)  Combined 16S rRNA gene sequencing and metabolomics to investigate the protective effects of Wu-tou decoction on rheumatoid arthritis in rats.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,  1199  (123249).  [PMID:35447521]
76. Hai-Peng Li, Zhi-Neng You, Yuan-Yang Liu, Gao-Wei Zheng, Heng Gong, Yiming Mo, Ning Zhu, Yun-Peng Bai, Jian-He Xu.  (2022)  Continuous-Flow Microreactor-Enhanced Clean NAD+ Regeneration for Biosynthesis of 7-Oxo-lithocholic Acid.  ACS Sustainable Chemistry & Engineering,  10  (1): (456–463).  [PMID:]
77. Ding Shen, Wei Hu, Suqing Zhao, Chuanbin Mao.  (2021)  Rapid Naked-Eye Detection of a Liver Disease Biomarker by Discovering Its Monoclonal Antibody to Functionalize Engineered Red-Colored Bacteria Probes.  ACS Omega,  6  (47): (32005–32010).  [PMID:34870023]
78. Shuai Xue,Jianli Yin,Jiawei Shao,Yuanhuan Yu,Linfeng Yang,Yidan Wang,Mingqi Xie,Martin Fussenegger,Haifeng Ye.  (2017-02-06)  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes..  Molecular therapy : the journal of the American Society of Gene Therapy,  25  ((2)): (443-455).  [PMID:28153094]
79. Chunli Qi,Jiangnan Fu,Huinan Zhao,Huijie Xing,Dong Dong,Baojian Wu.  (2018-02-14)  Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin..  Xenobiotica; the fate of foreign compounds in biological systems,  49  ((3)): (276-283).  [PMID:29436891]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.